BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38033949)

  • 1. Differential expression of Cadherins switch and Caveolin-2 during stages of oral carcinogenesis.
    Nascimento RB; Machado IAR; Silva JC; Faria LAS; Borba FC; Porto LPA; Santos JN; Ramalho LMP; Rodini CO; Rodrigues MFSD; Paiva KBS; Xavier FCA
    J Oral Maxillofac Pathol; 2023; 27(3):507-514. PubMed ID: 38033949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
    Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
    Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
    Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
    Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid droplets' functional protein caveolin-2 is associated with lipid metabolism-related molecule FABP5 and EMT marker E-cadherin in oral epithelial dysplasia.
    Chen XJ; Bai YT; Xie JR; Zhou G
    J Clin Pathol; 2024 Apr; 77(5):330-337. PubMed ID: 36854623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin.
    Min A; Xiong H; Wang W; Hu X; Wang C; Mao T; Yang L; Huang D; Xia K; Su T
    J Oral Pathol Med; 2020 Nov; 49(10):1019-1029. PubMed ID: 32740991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis.
    de Freitas Silva BS; Yamamoto-Silva FP; Pontes HA; Pinto Júnior Ddos S
    J Oral Pathol Med; 2014 Feb; 43(2):125-31. PubMed ID: 23772858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
    Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
    Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Expression of Epithelial Mesenchymal Transition Proteins in Squamous Cell Carcinoma of the Oral Cavity.
    Kadeh H; Saravani S; Miri Moghaddam E
    Iran J Pathol; 2021; 16(4):354-361. PubMed ID: 34567183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Correlative Study of N-Cadherin Expression with Different Grades of Oral Squamous Cell Carcinoma Projecting as a Marker of Epithelial to Mesenchymal Transition in Tumor Progression.
    Rai K H; Ahmed J
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2327-2332. PubMed ID: 31450902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
    da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
    Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
    Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
    J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential caveolin-1 expression in colon carcinoma and its relation to E-cadherin-β-catenin complex.
    Alshenawy HA; Ali MA
    Ann Diagn Pathol; 2013 Dec; 17(6):476-82. PubMed ID: 23830349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadherin switching in oral squamous cell carcinoma: A clinicopathological study.
    Ali AN; Ghoneim SM; Ahmed ER; El-Farouk Abdel Salam LO; Anis Saleh SM
    J Oral Biol Craniofac Res; 2023; 13(4):486-494. PubMed ID: 37293580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of Twist and relation with epithelial-mesenchymal transition in oral squamous cell carcinoma].
    Sun HX; Feng H; Song Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Oct; 33(5):534-8. PubMed ID: 26688951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunodetection of Epithelial-Mesenchymal Transition and Tumor Proliferation Markers in GLi-1-positive Oral Squamous Cell Carcinoma.
    Dantas RCM; Guimarães VSN; de Souza RO; Valverde LF; Vidal MTA; Nogueira RLR; da Rocha LOS; Araújo GT; Dos Santos JN; Rocha CAG
    Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):335-344. PubMed ID: 32769440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
    Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
    Gholami S; Chamorro-Petronacci C; Pérez-Sayáns M; Suárez Peñaranda J; Longatto-Filho A; Baltazar F; Afonso J
    J Appl Oral Sci; 2023; 31():e20220461. PubMed ID: 37194791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
    Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.
    Kaur J; Sawhney M; DattaGupta S; Shukla NK; Srivastava A; Walfish PG; Ralhan R
    PLoS One; 2013; 8(6):e67361. PubMed ID: 23840677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.